ARTICLE | Distillery Therapeutics
Enhancing dopamine receptor and ghrelin receptor activity to prevent β amyloid damage
August 22, 2019 9:52 PM UTC
INDICATION: Alzheimer's disease (AD) ...
BCIQ Company Profiles
INDICATION: Alzheimer's disease (AD) ...
BCIQ Company Profiles
BCIQ Company Profiles